Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior

被引:162
作者
Borowsky, AD
Namba, R
Young, LJT
Hunter, KW
Hodgson, JG
Tepper, CG
McGoldrick, ET
Muller, WJ
Cardiff, R
Gregg, JP
机构
[1] Univ Calif Davis, Dept Comparat Med, Ctr Comparat Med, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA
[3] NCI, Lab Populat Genet, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[4] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[5] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA
[6] McGill Univ, Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada
关键词
Akt; breast; breast carcinoma; cell line metastasis; comparative genomic hybridization; ERBB2; gene expression analysis; LY294002; mammary fat pad; mouse mammary tumor virus long terminal repeat; oncogene; orthotopic; phosphatidylinositol; 3; kinase; polyoma middle T; pulmonary metastasis; Sept9; Spp1; osteopontin; Opn; syngeneic; transgenic; tumor transplant;
D O I
10.1007/s10585-005-2908-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two cell lines, Met-1(fvb2) and DB-7(fvb2), with different metastatic potential, were derived from mammary carcinomas in FVB/N-Tg(MMTV-PyVmT) and FVB/N-Tg(MMTV-PyVmT(Y315F/Y322F)) mice, transplanted into syngeneic FVB/N hosts and characterized. The lines maintain a stable morphological and biological phenotype after multiple rounds of in vitro culture and in vivo transplantation. The Met-1(fvb2) line derived from a FVB/N-Tg(MMTV-PyVmT) tumor exhibits invasive growth and 100% metastases when transplanted into the females FVB/N mammary fat pad. The DB-7(fvb2) line derived from the FVB/N-Tg(MMTV-PyVmT(Y315F/Y322F)) with a "double base" modification at Y315F/Y322F exhibits more rapid growth when transplanted into the mammary fat pad, but a lower rate of metastasis (17%). The Met1(fvb2) cells show high activation of AKT, while DB-7(fvb2) cells show very low levels of AKT activation. The DNA content and gene expression levels of both cell lines are stable over multiple generations. Therefore, these two cell lines provide a stable, reproducible resource for the study of metastasis modulators, AKT molecular pathway interactions, and gene target and marker discovery.
引用
收藏
页码:47 / 58
页数:12
相关论文
共 38 条
[1]   Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours [J].
Baribault, H ;
WilsonHeiner, M ;
Muller, W ;
Penner, J ;
Bakhiet, N .
TRANSGENIC RESEARCH, 1997, 6 (06) :359-367
[2]  
Basu GD, 2004, MOL CANCER RES, V2, P632
[3]  
Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.3.CO
[4]  
2-S
[5]   The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting [J].
Cardiff, RD ;
Anver, MR ;
Gusterson, BA ;
Hennighausen, L ;
Jensen, RA ;
Merino, MJ ;
Rehm, S ;
Russo, J ;
Tavassoli, FA ;
Wakefield, LM ;
Ward, JM ;
Green, JE .
ONCOGENE, 2000, 19 (08) :968-988
[6]  
Cheung ATW, 1997, INT J ONCOL, V11, P69
[7]   A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers [J].
Cozma, D ;
Lukes, L ;
Rouse, J ;
Qiu, TH ;
Liu, ET ;
Hunter, KW .
GENOME RESEARCH, 2002, 12 (06) :969-975
[8]   Polyoma virus middle T antigen and its role in identifying cancer-related molecules [J].
Dilworth, SM .
NATURE REVIEWS CANCER, 2002, 2 (12) :951-956
[9]   ISOLATION AND CULTURE OF HEPATIC LIPOCYTES, KUPFFER CELLS, AND SINUSOIDAL ENDOTHELIAL-CELLS BY DENSITY GRADIENT CENTRIFUGATION WITH STRACTAN [J].
FRIEDMAN, SL ;
ROLL, FJ .
ANALYTICAL BIOCHEMISTRY, 1987, 161 (01) :207-218
[10]   Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5′ MUC1 promoter sequence and the middle T oncogene, expressed from the MMTV promoter [J].
Graham, RA ;
Morris, JR ;
Cohen, EP ;
Taylor-Papadimitriou, J .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (03) :382-387